Aadi Bioscience Inc.

NASDAQ: AADI · Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM

Aadi Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
25.98M 24.35M 15.22M 1M
Cost of Revenue
3.02M 2.81M 1.33M 276K
Gross Profit
22.96M 21.55M 13.88M 724K
Operating Income
-67.46M -71.93M -58.96M -111.22M
Interest Income
3.92M 6.4M 2.4M 13K
Pretax Income
-63.69M -65.77M -60.51M -110.09M
Net Income
-63.69M -65.77M -57.01M -110.09M
Selling & General & Admin
36.75M 44.55M 40.18M 18.51M
Research & Development
51.03M 48.93M 32.66M 19.67M
Other Expenses
2.64M n/a n/a -120K
Operating Expenses
90.42M 93.48M 72.84M 38.06M
Interest Expense
154K 231K 230K 665K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
93.44M 96.29M 74.17M 38.06M
Income Tax Expense
n/a n/a -3.5M 2K
Shares Outstanding (Basic)
26.99M 26.92M 22.51M 8.92M
Shares Outstanding (Diluted)
27.03M 26.92M 22.51M 8.92M
EPS (Basic)
-2.36 -2.44 -2.53 -12.34
EPS (Diluted)
-2.36 -2.44 -2.53 -12.34
EBITDA
-64.63M -65.36M -60.12M -109.15M
EBIT
-64.82M -65.53M -60.28M -109.42M
Depreciation & Amortization
193K 169K 159K 276K